Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

MRI versus mammography plus ultrasound in women at intermediate breast cancer risk: study design and protocol of the MRIB multicentre randomized controlled trial

View ORCID ProfileLuigina Ada Bonelli, View ORCID ProfileMassimo Calabrese, Paolo Belli, Stefano Corcione, Claudio Losio, View ORCID ProfileStefania Montemezzi, View ORCID ProfileFederica Pediconi, View ORCID ProfileAntonella Petrillo, Chiara Zuiani, Lucia Camera, View ORCID ProfileLuca Alessandro Carbonaro, View ORCID ProfileAndrea Cozzi, Daniele De Falco Alfano, View ORCID ProfileLicia Gristina, View ORCID ProfileMarta Panzeri, Ilaria Poirè, View ORCID ProfileSimone Schiaffino, Simona Tosto, View ORCID ProfileGiovanna Trecate, View ORCID ProfileRubina Manuela Trimboli, View ORCID ProfileFrancesca Valdora, Sara Viganò, View ORCID ProfileFrancesco Sardanelli
doi: https://doi.org/10.1101/2021.03.10.21253341
Luigina Ada Bonelli
1Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luigina Ada Bonelli
  • For correspondence: luiginaada.bonelli@hsanmartino.it
Massimo Calabrese
2Unit of Diagnostic Senology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Massimo Calabrese
Paolo Belli
3Department of Radiological, Radiotherapic and Hematological Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Corcione
4Breast Imaging Unit, Arcispedale Sant’Anna, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Losio
5Unit of Senology, IRCCS Ospedale San Raffaele, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefania Montemezzi
6Unit of Radiology BT, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stefania Montemezzi
Federica Pediconi
7Department of Radiological, Oncological and Pathological Sciences, Università degli Studi “La Sapienza”, Roma, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Federica Pediconi
Antonella Petrillo
8Radiology Unit, Istituto Nazionale dei Tumori IRCCS Fondazione G. Pascale, Napoli, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Antonella Petrillo
Chiara Zuiani
9Institute of Radiology, Azienda Ospedaliera Universitaria “S. Maria della Misericordia ”, Università degli Studi di Udine, Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lucia Camera
6Unit of Radiology BT, Azienda Ospedaliera Universitaria Integrata, Verona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luca Alessandro Carbonaro
10Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Luca Alessandro Carbonaro
Andrea Cozzi
11Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea Cozzi
Daniele De Falco Alfano
4Breast Imaging Unit, Arcispedale Sant’Anna, Azienda Ospedaliero-Universitaria di Ferrara, Cona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Licia Gristina
2Unit of Diagnostic Senology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Licia Gristina
Marta Panzeri
5Unit of Senology, IRCCS Ospedale San Raffaele, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marta Panzeri
Ilaria Poirè
1Unit of Clinical Epidemiology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Schiaffino
10Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Simone Schiaffino
Simona Tosto
2Unit of Diagnostic Senology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanna Trecate
12Diagnostica per Immagini, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giovanna Trecate
Rubina Manuela Trimboli
11Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rubina Manuela Trimboli
Francesca Valdora
2Unit of Diagnostic Senology, IRCCS Ospedale Policlinico San Martino, Genova, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francesca Valdora
Sara Viganò
12Diagnostica per Immagini, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Sardanelli
10Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Italy
11Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milano, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Francesco Sardanelli
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background In women at high/intermediate lifetime risk of breast cancer (BC-LTR), contrast-enhanced magnetic resonance imaging (MRI) added to mammography ±ultrasound (Mx±US) increases sensitivity but decreases specificity. An alternative strategy, MRI alone, potentially more cost-effective, has never been explored. This study aims to assess the characteristics of women who participated in a randomized trial offering MRI alone.

Methods In this feasibility multicentre randomized controlled trial we compared MRI alone versus Mx+US in women at intermediate BC-risk (allocation ratio 1:1). Eligible women were aged 40 –59, with a 15–30% LTR and/or extremely dense breasts. Two screening rounds per woman were planned in ten centres experienced in MRI screening. Primary endpoint: rate of cancers detected in the two arms after 5 years of follow-up. Secondary endpoints: distribution of the risk profiles among the women enrolled in the trial; distribution of pathological stages and histology of cancers detected; interval cancer rate in the two arms.

Results From 07/2013 to 11/2015, 1,254 women (mean age 47 years) were enrolled: 624 were assigned to Mx+US, 630 to MRI. Most of them were aged below 50 (72%) and premenopausal (45%), 52% used oral contraceptives. Among postmenopausal women, 15% had used hormone replacement therapy. Breast and/or ovarian cancer in mother and/or sisters were reported by 37% of enrolled women, extreme breast density was recorded for 79%, 41% had a 15–30% BC-LTR.

Conclusions The distribution of BC-risk profile major determinants (breast density and family of breast and ovarian cancer) of enrolled women varied across centres.

Trial registration NCT02210546

Key points

  • Mammography plus ultrasound are commonly used to screen women with dense breasts

  • Supplemental ultrasound increases BC detection rate but also false-positives and potential overdiagnosis

  • Whether increased BC detection by US translates into reduced mortality is unknown

  • MRI alone could be more risk- and cost-effective than mammography plus ultrasound

Competing Interest Statement

Stefania Montemezzi declares to have received grants as a member of a medical advisory board for Leika and as speaker for Bayer. Simone Schiaffino declares to have received travel support from Bracco Imaging and to be member of speakers' bureau for General Electric Healthcare. Francesco Sardanelli declares to have received grants from or to be a member of speakers' bureau or advisory board for Bayer, Bracco, and General Electric. All other authors declare that they have no competing interests to disclose.

Clinical Trial

NCT02210546

Funding Statement

This study received funding from the Italian Ministry of Health through the "Ricerca Finalizzata" program (RF-2009-1539582). Bracco s.p.a. provided additional financial support and supplied contrast agent doses, without having any influence on the study planning phase or on patient recruitment, nor having any access to the study database.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Ethics Committee of Regione Liguria for the coordinating centre and by the Ethics Committees of all participating centres. All enrolled women signed a written informed consent including a data publication section.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† Dr. Stefano Corcione passed away on February 18, 2018

  • ↵* Now at Department of Radiology, Grande Ospedale Metropolitano Niguarda, Piazza dell’Ospedale Maggiore 3, 20162, Milano, Italy; Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, via Festa del Perdono 7, 20122 Milano, Italy

  • ↵§ Now at Centro Mammografico, U.O. di Radiologia, Policlinico Sant’Orsola-Malpighi, Bologna, Italy

  • ↵⁂ Now at Breast Imaging and Screening Unit, Department of Radiology, Humanitas Clinical and Research Center - IRCCS, Via Manzoni 56, 20089 Rozzano, Italy

  • Declarations

  • Ethics approval, consent to participate, consent for publication This study was approved by the Ethics Committee of Regione Liguria for the coordinating centre and by the Ethics Committees of all participating centres. All enrolled women signed a written informed consent including a data publication section.

  • Availability of data and material This article details the study design and characteristics of patients enrolled in the “MRIB” multicentre randomized controlled trial. All remaining study data will be the object of a separate publication.

  • Funding This study received funding from the Italian Ministry of Health through the “Ricerca Finalizzata” program (RF-2009-1539582). Bracco s.p.a. provided additional financial support and supplied contrast agent doses, without having any influence on the study planning phase or on patient recruitment, nor having any access to the study database.

  • Competing interests Stefania Montemezzi declares to have received grants as a member of a medical advisory board for Leika and as speaker for Bayer. Simone Schiaffino declares to have received travel support from Bracco Imaging and to be member of speakers’ bureau for General Electric Healthcare. Francesco Sardanelli declares to have received grants from or to be a member of speakers’ bureau or advisory board for Bayer, Bracco, and General Electric. All other authors declare that they have no competing interests to disclose.

  • L.A. Bonelli and F. Sardanelli performed statistical analysis.

  • All authors participated to manuscript drafting and reviewing

  • All authors read and approved the final manuscript.

Data Availability

This article details the study design and characteristics of patients enrolled in the "MRIB" multicentre randomized controlled trial. All remaining study data will be the object of a separate publication.

  • Abbreviations

    ACR
    American College of Radiology;
    BC
    breast cancer
    BD
    breast density;
    HRT
    postmenopausal hormone replacement therapy;
    MRI
    contrast-enhanced magnetic resonance imaging;
    Mx
    mammography;
    RCT
    randomized controlled trial
    US
    breast ultrasound.
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted March 12, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    MRI versus mammography plus ultrasound in women at intermediate breast cancer risk: study design and protocol of the MRIB multicentre randomized controlled trial
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    MRI versus mammography plus ultrasound in women at intermediate breast cancer risk: study design and protocol of the MRIB multicentre randomized controlled trial
    Luigina Ada Bonelli, Massimo Calabrese, Paolo Belli, Stefano Corcione, Claudio Losio, Stefania Montemezzi, Federica Pediconi, Antonella Petrillo, Chiara Zuiani, Lucia Camera, Luca Alessandro Carbonaro, Andrea Cozzi, Daniele De Falco Alfano, Licia Gristina, Marta Panzeri, Ilaria Poirè, Simone Schiaffino, Simona Tosto, Giovanna Trecate, Rubina Manuela Trimboli, Francesca Valdora, Sara Viganò, Francesco Sardanelli
    medRxiv 2021.03.10.21253341; doi: https://doi.org/10.1101/2021.03.10.21253341
    Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    Citation Tools
    MRI versus mammography plus ultrasound in women at intermediate breast cancer risk: study design and protocol of the MRIB multicentre randomized controlled trial
    Luigina Ada Bonelli, Massimo Calabrese, Paolo Belli, Stefano Corcione, Claudio Losio, Stefania Montemezzi, Federica Pediconi, Antonella Petrillo, Chiara Zuiani, Lucia Camera, Luca Alessandro Carbonaro, Andrea Cozzi, Daniele De Falco Alfano, Licia Gristina, Marta Panzeri, Ilaria Poirè, Simone Schiaffino, Simona Tosto, Giovanna Trecate, Rubina Manuela Trimboli, Francesca Valdora, Sara Viganò, Francesco Sardanelli
    medRxiv 2021.03.10.21253341; doi: https://doi.org/10.1101/2021.03.10.21253341

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Radiology and Imaging
    Subject Areas
    All Articles
    • Addiction Medicine (76)
    • Allergy and Immunology (196)
    • Anesthesia (54)
    • Cardiovascular Medicine (489)
    • Dentistry and Oral Medicine (90)
    • Dermatology (56)
    • Emergency Medicine (168)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
    • Epidemiology (5689)
    • Forensic Medicine (3)
    • Gastroenterology (216)
    • Genetic and Genomic Medicine (868)
    • Geriatric Medicine (88)
    • Health Economics (232)
    • Health Informatics (762)
    • Health Policy (392)
    • Health Systems and Quality Improvement (254)
    • Hematology (105)
    • HIV/AIDS (182)
    • Infectious Diseases (except HIV/AIDS) (6488)
    • Intensive Care and Critical Care Medicine (391)
    • Medical Education (117)
    • Medical Ethics (28)
    • Nephrology (93)
    • Neurology (850)
    • Nursing (44)
    • Nutrition (141)
    • Obstetrics and Gynecology (163)
    • Occupational and Environmental Health (262)
    • Oncology (514)
    • Ophthalmology (163)
    • Orthopedics (44)
    • Otolaryngology (107)
    • Pain Medicine (48)
    • Palliative Medicine (21)
    • Pathology (149)
    • Pediatrics (250)
    • Pharmacology and Therapeutics (146)
    • Primary Care Research (114)
    • Psychiatry and Clinical Psychology (969)
    • Public and Global Health (2231)
    • Radiology and Imaging (377)
    • Rehabilitation Medicine and Physical Therapy (174)
    • Respiratory Medicine (312)
    • Rheumatology (109)
    • Sexual and Reproductive Health (81)
    • Sports Medicine (82)
    • Surgery (118)
    • Toxicology (25)
    • Transplantation (34)
    • Urology (42)